The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 20, 2021
Filed:
Jan. 11, 2017
Applicant:
Visiongate, Inc., Phoenix, AZ (US);
Inventors:
Alan C. Nelson, Phoenix, AZ (US);
Michael G. Meyer, Phoenix, AZ (US);
Daniel J. Sussman, Tempe, AZ (US);
Assignee:
VisionGate, Inc., Phoenix, AZ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/167 (2006.01); G06T 7/00 (2017.01); G01N 33/483 (2006.01); A61K 31/5578 (2006.01); A61K 31/593 (2006.01); G01N 15/14 (2006.01); G06K 9/00 (2006.01); G01N 15/10 (2006.01);
U.S. Cl.
CPC ...
G06T 7/0012 (2013.01); A61K 31/167 (2013.01); A61K 31/5578 (2013.01); A61K 31/593 (2013.01); G01N 15/14 (2013.01); G01N 15/1434 (2013.01); G01N 15/1468 (2013.01); G01N 33/4833 (2013.01); G06K 9/00147 (2013.01); G06K 9/00201 (2013.01); G01N 2015/1006 (2013.01); G01N 2015/1445 (2013.01); G06T 2207/10101 (2013.01); G06T 2207/30024 (2013.01);
Abstract
A method of treating a malignancy in a human subject by analyzing pseudo-projection images of cells obtained from a sputum specimen obtained from a subject employs a biological specimen classifier that identifies cells from the sputum specimen as normal or abnormal. If abnormal cells are detected, then the abnormal cells are further classified as dysplastic or cancerous. If the cells are classified as dysplastic, then an immunomodulating agent is administered to the subject over a predetermined time period designed to achieve a therapeutic dosage.